Merck investigates acquisition of Biotech Seagen

Merck & Co. looking at a purchase of biotechnology Seagen According to people familiar with the matter, a move that would strengthen the pharmaceutical giant’s portfolio of cancer drugs.

Talks have been going on for some time, and an agreement is not Slot Bonus New Member, the people said, warning that it could be difficult to withdraw one of them given the increased risk of a regulatory challenge. It is possible the companies may end up entering into a marketing agreement instead, some of the people said.